- Inhibition of the breast cancer by PPARγ agonist pioglitazone through…
Number of the records: 1  

Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway

  1. TitleInhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway / X. X. Jiao ... [et al.]
    Another responsib. Jiao, X. X. (Author)
    Phys.des.ilustr., aj fareb., grafy, obr.
    NoteBibliogr. odkazy. Res. angl.
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 67, no. 4 (2020), s. 834-842
    Call numberC 720
    MeSH Subject nádory prsníka
    PPAR gama - agonisty
    pioglitazón
    línia bunková nádorová
    myši inbredné BALB C
    Keywords štúdia experimentálna
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.